Key result
Lack of coronary collaterals in revascularized STEMI linked to ~5.7-fold higher intramyocardial hemorrhage risk.
Why the study?
Does the presence of coronary collaterals reduce intramyocardial hemorrhage in STEMI patients undergoing primary PCI?
Observational (n=294)
Blinded outcome assessment
Does the presence of coronary collaterals reduce intramyocardial hemorrhage in STEMI patients undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
The presence and extent of coronary collaterals are significant protective determinants against the development of lethal intramyocardial hemorrhage and microvascular obstruction in STEMI patients undergoing primary PCI.
BACKGROUND: Intramyocardial hemorrhage (IMH), evident in 40% of revascularized ST-segment elevation myocardial infarction (STEMI) patients, is a lethal determinant of MI size. IMH compromises myocardial salvage and drives major adverse cardiovascular events. OBJECTIVES: We sought to determine whether the presence and extent of coronary collaterals affect development of IMH in STEMI patients. METHODS: The MIRON-CL trial (NCT05898425) enrolled 294 consecutive STEMI patients reperfused via primary percutaneous coronary intervention (PCI). All underwent pre-PCI angiography to determine Rentrop collateral grades (0: none; III: complete). Three days post-PCI cardiac magnetic resonance imaging quantified myocardial area at risk (T2 edema), IMH (T2∗), and MI (late gadolinium enhancement). RESULTS: Among 294 patients, 124 had IMH and 170 did not. Patients with no collaterals (CL-, Grade 0) had higher IMH (7.41% ± 5.33% left ventricle) than those with collaterals (CL+; Grade I: 5.23% ± 3.21%, II: 3.11% ± 2.78%, III: 2.05% ± 1.89%; P < 0.001). Total area at risk post-PCI was larger in CL- (37.62% ± 15.32% left ventricle) than in CL+ (21.48% ± 13.21%; P < 0.001). Absence of collaterals correlated with larger MI (CL- 38.66% ± 14.63% vs CL+ 19.84% ± 13.72%; P < 0.001) and higher microvascular obstruction (CL- 8.07% ± 6.60% vs CL+ 2.17% ± 2.35%; P < 0.001). Patients without collaterals had a higher adjusted risk of IMH (OR: 5.71; 95% CI: 3.16-10.33; P < 0.0001). CONCLUSIONS: Extent of coronary collaterals is a determinant of IMH in revascularized STEMI. Since IMH is known to drive post-PCI infarct expansion, determination of collateral status has the potential to identify patients at high risk of infarct expansion. For these high-risk patients, novel targeted therapies to reduce IMH, limit post-MI infarct expansion, and improve outcomes should be further explored.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2025) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=294). Absence of coronary collaterals (Rentrop Grade 0) vs. Presence of coronary collaterals (Rentrop Grades I-III) was evaluated on Development of intramyocardial hemorrhage (IMH) (OR 5.71, 95% CI 3.16-10.33, p=<0.0001). The absence of coronary collaterals in revascularized STEMI patients was associated with a higher risk of developing intramyocardial hemorrhage.
Synapse has enriched 10 related papers. Consider them for comparative context: